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Occludin is an integral membrane protein that is tyrosine phosphorylated when localized at tight
junctions. When Ca2 was depleted from the culture medium, occludin tyrosine phosphorylation
was diminished from Madin-Darby canine kidney epithelial cells in 2 min. This dephosphoryla-
tion was correlated with a significant reduction in transepithelial electrical resistance (TER),
indicating a global loss of the tight junction barrier function. Reconstitution of Ca2 resulted in a
robust tyrosine rephosphorylation of occludin that was temporally associated with an increase in
TER. Moreover, we demonstrate in this study that occludin was colocalized with the nonreceptor
tyrosine kinase c-Yes at cell junction areas and formed an immunoprecipitable complex with c-Yes
in vivo. This complex dissociated when the cells were incubated in medium without Ca2 or
treated with a c-Yes inhibitor, CGP77675. In the presence of CGP77675 after Ca2 repletion,
occludin tyrosine phosphorylation was completely abolished and both tight junction formation
and the increase of the TER were inhibited. Our study thus provides strong evidence that occludin
tyrosine phosphorylation is tightly linked to tight junction formation in epithelial cells, and that
the nonreceptor tyrosine kinase c-Yes is involved in the regulation of this process.
INTRODUCTION
A number of tight junction integral membrane proteins and
tight junction-associated proteins have been identified in the
last decade: occludin, the claudin family, junctional adhe-
sion molecule, zonula occludens (ZO)-1, ZO-2, ZO-3, cingu-
lin, symplekin, and AF6 (reviewed in Stevenson and Keon,
1998; Goodenough, 1999; Tsukita et al., 1999). Among these,
occludin is an integral membrane protein localized within
the freeze fracture fibrils that has been shown to be required
for normal tight junction physiology (Furuse et al., 1993;
Fujimoto, 1995; Balda et al., 1996; McCarthy et al., 1996; Chen
et al., 1997; Wong and Gumbiner, 1997). Occludin has a
predicted tetraspanning membrane topology with two ex-
tracellular loops and three cytoplasmic domains (Furuse et
al., 1993; Ando-Akatsuka et al., 1996). It has been shown that
the extracellular loops are important for occludin localiza-
tion in culture (Wong and Gumbiner, 1997; Lacaz-Vieira et
al., 1999; Medina et al., 2000). The C terminus of occludin
directly interacts with ZO-1 in vitro and is required for tight
junction function (Furuse et al., 1994; Balda et al., 1996; Chen
et al., 1997; Matter and Balda, 1998; Mitic et al., 1999).
Occludin migrates as a tight cluster of multiple bands on
SDS gels resulting from multiple phosphorylation of serine
and threonine residues (Sakakibara et al., 1997; Wong, 1997;
Cordenonsi et al., 1999; Farshori and Kachar, 1999). It has
been suggested that the phosphorylation of occludin is im-
portant for tight junction assembly because highly phos-
phorylated occludin is selectively concentrated at tight junc-
tions in a detergent-insoluble form (Sakakibara et al., 1997).
However, in epithelia of Xenopus embryos, occludin dephos-
phorylation was correlated with the de novo assembly of
tight junctions (Cordenonsi et al., 1999), suggesting that oc-
cludin phosphorylation may play different roles in different
biological systems, or that phosphorylation of specific resi-
dues has different functional consequences.
Studies of tyrosine phosphorylation have revealed contra-
dictory data on tight junction physiology. Inhibition of phos-
phatase activity has been reported to result in decreases in
transepithelial electrical resistance (TER) and increases in
paracellular permeability (Staddon et al., 1995; Collares-
Buzato et al., 1998; Atkinson and Rao, 2001). However, other
studies have shown that tyrosine phosphorylation can be
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positively temporally correlated with tight junction assem-
bly and function (Kurihara et al., 1995; Tsukamoto and
Nigam, 1999). Tsukamoto and Nigam (1999) provided the
first evidence that occludin was tyrosine phosphorylated
and that tyrosine kinase activity is necessary for tight junc-
tion reassembly during ATP repletion.
The signaling pathways and kinases involved in occludin
phosphorylation and tight junction function remain unclear.
Overexpression of protein kinase C (PKC)- (Mullin et al.,
1998) or phorbol ester activation of PKC (Clarke et al., 2000)
leads to the dephosphorylation of occludin and increased
tight junction permeability in LLC-PK1 renal epithelial cells.
It has been shown that epidermal growth factor induces
tyrosine phosphorylation and reorganization of ZO-1 in
A431 human epidermal carcinoma cells (Van Itallie et al.,
1995). Small GTPases, such as Rho and Rac, are also in-
volved in regulating tight junction structure and function
(Nusrat et al., 1995; Gopalakrishnan et al., 1998; Jou et al.,
1998). Other signaling molecules reported to influence the
function of the tight junction include G proteins, phospho-
lipase C, Raf-1, calmodulin, and glucocorticoids (Balda et al.,
1991; Singer et al., 1994; Denker et al., 1996; Saha et al., 1998;
Li and Mrsny, 2000).
Our previous work demonstrated that in ras-transformed
Madin-Darby canine kidney (MDCK) cells tight junction
structure is absent, and occludin, claudin-1, and ZO-1 are
present only in the cytoplasm (Chen et al., 2000). Under these
conditions, occludin is not tyrosine phosphorylated. When
Ras signaling is attenuated by the inhibition of the mitogen-
activated protein kinase pathway, tight junctions are re-
stored. Occludin, claudin-1, and ZO-1 are concomitantly
recruited to the cell-cell contact areas and occludin becomes
tyrosine phosphorylated. In the present study, we have used
normal MDCK II cells to investigate whether occludin ty-
rosine phosphorylation is required for tight junction forma-
tion in epithelial cells. Using a calcium-switch model, we
found that occludin tyrosine phosphorylation and dephos-
phorylation were temporally highly correlated with tight
junction assembly and disassembly. Furthermore, we dem-
onstrate that occludin was colocalized and formed an im-
munoprecipitable complex with the nonreceptor tyrosine
kinase c-Yes in vivo. Treatment of MDCK cells with a c-Yes
inhibitor, CGP77675, disrupted the occludin/c-Yes complex
and completely abolished the tyrosine phosphorylation of
occludin. Our study provides strong evidence that occludin
tyrosine phosphorylation is required for tight junction for-
mation in epithelial cells, and that the nonreceptor tyrosine
kinase c-Yes is involved in the regulation of tight junction
formation and function.
MATERIALS AND METHODS
Antibodies and Reagents
The rabbit polyclonal anti-occludin, anti-claudin-1, and anti-ZO-1
antibodies were purchased from Zymed Laboratories (South San
Francisco, CA). The mouse anti-phosphotyrosine and mouse anti-
c-Yes monoclonal antibodies (mAbs) were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA) and Transduction Laborato-
ries (Lexington, KY), respectively. Genistein, a broad-range tyrosine
kinase inhibitor that inhibits epidermal growth factor receptor ty-
rosine kinase and p60v-src kinase, was obtained from Calbiochem
(San Diego, CA). The c-Yes inhibitor CGP77675 was kindly pro-
vided by Dr. Mira Susa (Novartis Pharma AG, Basel, Switzerland).
Fluorescein isothiocyanate-conjugated goat anti-rabbit IgG was pur-
chased from Roche Applied Sciences (Indianapolis, IN). Rhoda-
mine-conjugated goat anti-mouse IgG was obtained from Cappel
(Malvern, PA).
Cell Culture and Calcium-Switch Assay
MDCK II cells were grown in DMEM containing 10% fetal bovine
serum, 100 U/ml penicillin, and 100 g/ml streptomycin in a hu-
midified air, 5% CO2 atmosphere at 37°C. During the calcium-
switch experiments, the monolayers were washed three times with
Ca2/Mg2-free phosphate-buffered saline (PBS) and incubated in
Ca2-free DMEM, 10% dialyzed fetal bovine serum for 1 h or
overnight depending on the experiments, and then switched to
normal culture medium. At the time of switching back to normal
medium the cells were either not treated (control), or treated with 50
M genistein, or with 200 nM CGP77675 for various lengths of time
before fixing for immunohistochemistry or lysed for immunopre-
cipitation.
Immunofluorescence and Confocal Microscopy
Cells grown on glass coverslips were fixed with 100% methanol at
20°C for 5 min. Cells were blocked with 2% bovine serum albumin
(BSA) for 30 min at room temperature and incubated with primary
antibodies against occludin (1:300 dilution), claudin-1 (1:100), ZO-1
(1:500), and c-Yes (1:500) for 1 h. All antibodies were diluted in 2%
BSA in PBS. After washing, cells were incubated with secondary
antibody for 50 min at room temperature. The secondary antibody
used for occludin, claudin-1, and ZO-1 was fluorescein isothiocya-
nate-conjugated anti-rabbit IgG (1:400). The rhodamine- (for double
labeling) conjugated anti-mouse IgG was used for c-Yes (1:400).
Coverslips were mounted with ProLong antifade kit (Molecular
Probes, Eugene, OR). Samples were analyzed and photographed
using either a Zeiss Axiophot or Zeiss Axiovert S100 (Carl Zeiss,
Thornwood, NY). The z-axial images were collected using a Zeiss
LSM 510 laser confocal scanning microscopy (Carl Zeiss).
Immunoprecipitation and Western Blot Analysis
MDCK II cells without treatment, with 50 M genistein, or with 200
nM CGP77675 were washed three times in PBS, and then lysed in
radioimmunoprecipitation assay (RIPA) buffer (1% Triton X-100;
0.5% sodium deoxycholate; 0.2% SDS; 150 mM NaCl; 10 mM
HEPES, pH 7.3; 2 mM EDTA; 10 g/ml each of chymostatin, leu-
peptin, and pepstatin A; 20 M phenylmethylsulfonyl fluoride; 2
mM sodium orthovanadate; 10 mM sodium pyrophosphate; and 20
mM sodium fluoride). After 20-min incubation at 4°C, the lysates
were homogenized on ice by passing 20 times through a 22-gauge
needle, and centrifuged at 15,000  g for 30 min at 4°C. The total
protein concentration of each sample was measured by bicincho-
ninic acid protein assay kit (Pierce Chemical, Rockford, IL) and
adjusted to equal concentration (1 mg/ml). After preclearing with
protein A- or protein G-Sepharose beads the supernatants were
incubated with polyclonal anti-occludin or anti-ZO-1 or monoclonal
anti-c-Yes antibody at 4°C overnight. The supernatants were incu-
bated with either protein A-Sepharose (for occludin and ZO-1) or
protein G (for c-Yes) for additional 2 h. The beads were washed
three times with RIPA buffer, one time with high salt (0.5 M NaCl),
and one time with Tris buffer (10 mM Tris, pH 7.4). Bound protein
was eluted from the beads in SDS sample buffer and boiled for 5
min.
Cell lysates or immunoprecipitates in SDS sample buffer were
separated by SDS-PAGE and transferred to nitrocellulose mem-
branes. The membrane was then blocked in 5% nonfat dried milk or
5% BSA (for anti-phosphotyrosine detection) in Tris-buffered saline
plus 0.1% Tween 20, and incubated with primary antibodies for
1.5 h followed by incubation with appropriate secondary antibodies
for 1 h. The dilutions for the primary antibodies were as follows:
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anti-occludin, 1:1000; anti-claudin-1, 1:500; anti-ZO-1, 1:2000; and
anti-phosphotyrosine, 1:300. After blotting, the signals were de-
tected by enhanced chemiluminescence (Amersham Biosciences,
Piscataway, NJ) on X-OMAT film. When necessary, blots were
stripped (100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mM Tris-
HCl, pH 7.6) for 30 min at 55°C. The blots were then washed in
Tris-buffered saline containing 0.1% Tween 20 before reprobing
with specific antibodies.
Measurement of TER
For TER measurements, cells were plated on Transwell filters with
a pore size of 0.4 m (Corning Glassworks, Cambridge, MA). A
Millicell-ERS volt-ohm meter (Millipore, Bedford, MA) was used to
determine the TER value (McCarthy et al., 1996). A pair of Ag/AgCl
electrodes was placed into the transwell (one electrode was inserted
into up-chamber and the other electrode was inserted into low-
chamber) and an AC square wave current from the volt-ohm meter
was passing across the cell monolayer to obtain the TER values. All
the TER values were determined after the background subtraction
(contributed by filter and bath solution) and multiplied by the
surface area of the filter.
RESULTS
Tyrosine Phosphorylation of Occludin Was
Diminished in Ca2-free Medium
Occludin was tyrosine phosphorylated in confluent MDCK
II cells when cultured in Ca2-containing medium as shown
in Figure 1A, lane 0. However, after switching to the me-
dium without Ca2, occludin tyrosine phosphorylation was
diminished within 2 min (Figure 1A, lane 2). In contrast,
ZO-1 tyrosine phosphorylation was unchanged until 60 min
after Ca2 depletion (Figure 1B). Occludin remained ty-
rosine dephosphorylated for as long as the cells remained in
the Ca2-free medium (Figure 1A, lanes 10, 30, and 60). An
initial sharp drop in TER was closely correlated with the
time of occludin tyrosine dephosphorylation (Figure 2).
Each TER measurement was normalized to the initial value
(the TER before switching to the Ca2-free medium, indi-
cated as 100% in Figure 2). TER continuously decreased over
the next hour until reaching its minimum. Immunohisto-
chemistry showed that the tight junction proteins occludin,
claudin-1, and ZO-1 were all still localized at the cell-cell
contact area after 2 min of Ca2 depletion, although the TER
had dropped 40% at this time point (Figure 3, A–C). After
10 min of Ca2 depletion, cells detached from each other and
the cell junctions were disrupted (Figure 3, D–F). The fluo-
rescence intensities of occludin, claudin-1, and ZO-1 on the
cell membrane were reduced and the staining pattern be-
came discontinuous. On the other hand, the cytoplasmic
staining of occludin, claudin-1, and ZO-1 increased. By 30
min of Ca2 depletion, cells were all dissociated from each
other, and the fluorescence staining patterns associated with
each of the tight junction proteins appeared punctate (Figure
3, G and H), or dispersed in the cytoplasm (Figure 3I). The
inserts provided in Figure 3, G–I, are enlarged images from
the same field.
Tyrosine Phosphorylation of Occludin Was
Associated with Tight Junction Formation during
Ca2 Repletion
To correlate occludin tyrosine rephosphorylation with tight
junction assembly, cells were switched back to Ca2-con-
taining culture medium after 1 h of Ca2 depletion. Tyrosine
phosphorylation of occludin appeared clearly at the 1-h time
point after Ca2 repletion and reached its maximum at 2 and
4 h (Figure 4A). The more slowly migrating band seen at the
0-, 0.5-, and 1-h time points was not occludin related because
it could not be stained when this membrane was stripped
Figure 1. Changes in tyrosine phosphorylation of occludin and
ZO-1 during Ca2 depletion. Cells were grown in Ca2-containing
medium until they were confluent (0 min). Then cells were switched
to the medium without Ca2 for 2, 10, 30, and 60 min. After Ca2
depletion at desired time points, cells were lysed in RIPA buffer,
immunoprecipitated with anti-occludin (A) or anti-ZO-1 (B), and
immunoblotted with anti-phosphotyrosine antibody.
Figure 2. TER measurements during Ca2 depletion. TER was
measured at 0, 2, 10, 30, and 60 min after cells were switched from
Ca2-containing medium to the medium without Ca2. Each TER
measurement was normalized to the TER value before switching to
the Ca2-free medium and was obtained after background subtrac-
tion (contributed by the filter and bath solution). The data represent
the average  SE from five experiments.
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and reprobed with anti-occludin antibody (our unpublished
data). The total amount of occludin at each time point in
Figure 4A was similar as determined by densitometry of
anti-occludin immunoblots (our unpublished data). The
changes in ZO-1 tyrosine phosphorylation during Ca2 re-
pletion were much less significant and not correlated with
the tight junction assembly (Figure 4B). The band below
ZO-1 was most likely ZO-2 because these molecules have
been shown to coimmunoprecipitate with ZO-1 under sim-
ilar experimental conditions (Gumbiner et al., 1991; Jesaitis
and Goodenough, 1994). Figure 4C documents that occludin
tyrosine phosphorylation reached a maximum at 2 and 4 h
and then declined to a steady-state level at 8 h. The level of
ZO-1 tyrosine phosphorylation did not show a detectable
change over the time course of these experiments (Figure
4D).
TER measurements revealed a close temporal correlation
between occludin tyrosine phosphorylation and tight junc-
tion formation during Ca2 repletion (Figure 5). Cells were
incubated in the Ca2-free medium for 1 h and then
switched to Ca2-containing culture medium. As presented
previously (Figure 2), each TER measurement was normal-
ized to the initial TER value (as 100%) before Ca2 depletion.
As shown in Figure 5, TER overshot its initial value at 2 and
4 h, at which time occludin tyrosine phosphorylation was
also at a maximum (Figure 4, A and C). TER then declined
to its initial value by 8 h (Figure 5) at which time the
occludin tyrosine phosphorylation had also returned to its
steady-state level (Figure 4, A and C).
Immunohistochemistry was consistent with the TER mea-
surements. There was no cell membrane staining with the
three tight junction markers after 1 h of Ca2 depletion
when the cells were rounded up (Figure 6, A–C). After 0.5 h
of Ca2 repletion, occludin, claudin-1, and ZO-1 started to
appear at some of the cell-cell contact areas (Figure 6, D–F).
The junctional staining of occludin, claudin-1, and ZO-1 was
more obvious at the 1-h time point as shown in Figure 6, G–I.
After the cells were switched back to Ca2-containing cul-
Figure 3. Immunolocalization of occludin, claudin-1, and ZO-1 after Ca2 was removed from the medium. Cells were grown in normal
culture medium until they were confluent, and then the cells were switched to the medium without Ca2 for 2, 10, and 30 min. The results
from immunofluorescence staining showed that 2 min after Ca2 was depleted from the medium, cell-cell contacts were still intact and
occludin, claudin-1, and ZO-1 were all localized at cell-cell contact area (A–C). However, after 10 min of Ca2 depletion, the cell junctions
were disrupted and the immunostaining of the tight junction proteins became discontinued (D–F). By 30 min of Ca2 depletion, cells were
detached from each other and the fluorescence staining patterns appeared either punctate (G and H) or dispersed in the cytoplasm (I). Bar,
20 m. The inserts in G–I are enlarged images selected in the same fields (arrowheads indicate the same cells) to show the localization of the
signals. Bar, 10 m.
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ture medium for 2 h, the tight junction was fully assembled
as indicated both by immunofluorescent staining (Figure 6,
J–L) and TER measurement (Figure 5).
Molecular Interaction of Occludin with Nonreceptor
Tyrosine Kinase c-Yes
Immunohistochemistry and immunoprecipitation were
used to identify an upstream tyrosine kinase of occludin.
Nusrat et al. (2000) demonstrated previously that a 27 ami-
no-acid peptide of the human occludin sequence interacts in
vitro with occludin itself, ZO-1, PKC-, c-Yes, the regulatory
subunit of phosphatidylinositol 3-kinase, and the gap junc-
tion component connexin26. Pursuing these findings, we
found that nonreceptor tyrosine kinase c-Yes was colocal-
ized with occludin at tight junctions and along basolateral
membranes in MDCK cells as demonstrated in Figure 7,
A–C. Confocal microscopy confirmed z-axis colocalization of
occludin and c-Yes to within confidence levels of the light
microscope (Figure 7, D–F). To determine whether occludin
and c-Yes form a stable complex in vivo, coimmunoprecipi-
tation experiments were performed. Figure 7G shows that
when MDCK II cell lysates were immunoprecipitated with
anti-occludin antibody, c-Yes was present in the complex as
revealed by immunoblot with an anti-c-Yes antibody. Recip-
rocal immunoprecipitation with anti-c-Yes antibody fol-
lowed by immunoblot with anti-occludin confirmed the in-
teraction of these two proteins in vivo (Figure 7H). This
complex was disrupted in Ca2-free medium (see below).
We were unable to detect claudin-1 in this complex as indi-
cated in Figure 7I, although claudin-1 was robustly present
in the cell lysates (Figure 7J). Both Src and phosphatidylino-
sitol 3-kinases were also undetectable in this complex (our
unpublished data).
Inhibition of c-Yes Results in Dissociation of
Occludin/c-Yes Complex and Disruption of Tight
Junction Formation
MDCK II cells were recovered from low Ca2 condition in
the presence of the tyrosine kinase inhibitors genistein and
CGP77675 to demonstrate a temporal correlation between
the presence of an occludin/c-Yes complex and tight junc-
tion reassembly. To completely dissociate cells from each
other and reduce overall background the overnight Ca2
depletion condition was used in tyrosine kinase inhibitor
experiments. Cells were grown overnight in Ca2-free me-
dium, and then changed to Ca2-containing medium without
Figure 4. Tyrosine phosphorylation of occludin and ZO-1 during
tight junction assembly after Ca2 repletion. Cells were incubated in
Ca2-free medium for 1 h (designated as 0 h) and then switched to
the Ca2-containing medium for 0.5, 1, 2, 4, and 6 h in A and B, or
for 2, 4, 8, and 24 h in C and D. After Ca2 repletion at designated
time points, cells were lysed in RIPA buffer, immunoprecipitated
with anti-occludin (A and C) or anti-ZO-1 (B and D), and immuno-
blotted with anti-phosphotyrosine antibody. Tyrosine phosphory-
lation of occludin appeared clearly at 1-h time point after Ca2
repletion (A) and reached maximum at 2- and 4-h time points (A
and C). Tyrosine phosphorylation of ZO-1 did not change signifi-
cantly over the time course of these experiments (B and D).
Figure 5. Time course of TER recovery during Ca2 repletion.
Cells were incubated in Ca2-free medium for 1 h and then
switched to the Ca2-containing medium for 0, 0.5, 1, 2, 4, and 8 h
at which time points the TER were measured. Each TER measure-
ment was normalized to the initial TER value (before switching to
the Ca2-free medium) and was obtained after background subtrac-
tion (contributed by filter and bath solution). The data represent the
average  SE from five experiments.
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(Figure 8A, lane C), or with the addition of 50 M genistein
(Figure 8A, lane Geni), or 200 nM CGP77675 (Figure 8A, lane
CGP). After 2.5 h, cells were lysed and immunoprecipitated
with anti-occludin antibody. All the immunoprecipitates were
then probed with anti-phosphotyrosine antibody. Figure 8A
shows that genistein treatment only slightly reduced the
amount of occludin that was tyrosine phosphorylated after
repletion of Ca2. In contrast, CGP77675 treatment completely
abolished the tyrosine phosphorylation of occludin under the
identical conditions. Indirect immunofluorescence light mi-
croscopy data revealed that CGP77675 treatment interfered
with tight junction assembly and denied monolayer formation
after switching to Ca2-containing medium for 2.5 h (Figure
8B, CGP). In contrast, the control cells or the cells treated with
genistein formed confluent monolayers with the characteristic
honeycomb-like staining of occludin and ZO-1 (Figure 8B, C
and Geni).
TER measurements also demonstrated the impairment of
tight junction formation after the cells were treated with c-Yes
inhibitor compared with the control cells and genistein-treated
cells (Figure 9). After the cells were switched to Ca2-contain-
ing medium for 3 h, the TER measured from the control cells
and the genistein-treated cells reached175% of the initial TER
value, whereas the TER from CGP77675-treated cells had only
50% of the initial TER value. The effect of CGP77675 was time
limited because TER values from all three conditions were
similar by 8 h (our unpublished data).
We examined the interaction of occludin with c-Yes tyrosine
kinase in Ca2-free medium and CGP77675-treated conditions.
Figure 10A shows that c-Yes and occludin were not associated
with each other in Ca2-free medium. In addition, when cells
were treated with CGP77675 for 2.5 h after switching to Ca2-
containing medium, the interaction of occludin and c-Yes was
greatly reduced compared with the control cells. Figure 10B
demonstrates that equivalent amounts of c-Yes were immuno-
precipitated under all three conditions. These data were con-
sistent with those shown in Figures 8A and 9 in which occludin
tyrosine phosphorylation was undetectable after CGP77675
treatment (Figure 8A) and the TER value in the presence of
CGP77675 was much lower compared with the control and
genistein-treated conditions (Figure 9).
DISCUSSION
In the present study we found that occludin tyrosine phos-
phorylation tightly correlated with the tight junction forma-
tion in a kidney epithelial cell line. During Ca2 depletion,
Figure 6. Recruitments of occludin,
claudin-1, and ZO-1 to the cell junc-
tion during Ca2 repletion. After in-
cubated in Ca2-free medium for 1 h,
cells were dissociated from each
other, and occludin, claudin-1, and
ZO-1 were largely present in the cy-
toplasm (A–C). After 0.5 h of Ca2
repletion, occludin, claudin-1, and
ZO-1 started to be recruited to some
of the cell-cell contact area (D–F). At
1-h time point, tight junction proteins
were well accumulated at cell junc-
tions (G–I). The tight junction stain-
ing of occludin, claudin-1, and ZO-1
completely returned to normal by 2 h
of Ca2 repletion (J–L). Bar, 20 m.
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the initial quick drop of TER was accompanied by a parallel
tyrosine dephosphorylation of occludin. The occurrence of
occludin tyrosine rephosphorylation after Ca2 repletion
was closely associated with an increase in TER. These
changes in tyrosine phosphorylation of occludin are signif-
icantly more rapid than occludin turnover (Chen et al., 2000),
indicating recycling of the occludin molecules at the tight
junction rather than degradation followed by de novo syn-
thesis. The intensity of occludin tyrosine phosphorylation
correlated with the TER value, because both showed a par-
allel overshoot 2–4 h after Ca2 repletion. In addition, we
demonstrated for the first time that the nonreceptor tyrosine
kinase c-Yes was colocalized with occludin at the tight junc-
tion and along basolateral membranes and that occludin and
c-Yes formed a complex in vivo by reciprocal coimmuno-
precipitation assay. These data do not reveal, however, that
occludin is the direct substrate for c-Yes tyrosine kinase
activity or that the tyrosine phosphorylation of occludin is a
necessary or sufficient condition for tight junction assembly.
Because tight junctions are known to form in mice depleted
of occludin (Saitou et al., 2000), more specific assays of
occludin function in the tight junction are required to dissect
the functional meaning of occludin tyrosine phosphoryla-
tion.
When the cells were treated with the c-Yes inhibitor
CGP77675 after Ca2 repletion, tight junction formation and
the establishment of the TER were inhibited or significantly
delayed. CGP77675 also disrupted the occludin/c-Yes com-
plex, and completely abolished the tyrosine rephosphoryla-
tion of occludin. Because CGP77675 inhibits both c-Src and
c-Yes (Missbach et al., 1999; Susa et al., 2000), we performed
our CGP77675 inhibition assays in parallel with genistein, an
inhibitor of both the epidermal growth factor receptor ki-
nase and p60v-src kinase (Akiyama et al., 1987; Nakanishi et
al., 1993; Laniyonu et al., 1995) and herbimycin A, a c-Src
tyrosine kinase inhibitor (Yoneda et al., 1993; Kuo et al.,
Figure 7. Colocalization and coimmunoprecipitation of occludin with nonreceptor tyrosine kinase c-Yes in canine kidney epithelial cells.
Confluent cells were fixed in methanol and processed for double immunofluorescence by using the rabbit anti-occludin (A) polyclonal
antibody and mouse anti-c-Yes (B) mAb antibody. Images of A and B were superimposed as C. Confocal fluorescence microscopy showed
the z-axis colocalization of occludin (D) and c-Yes (E) and their superimposed image (F). Occludin and c-Yes formed a complex in vivo. Cells
were lysed with RIPA buffer and immunoprecipitated with either anti-occludin and blotted with anti-c-Yes (G), or immunoprecipitated with
anti-c-Yes and blotted with anti-occludin (H). As a negative control, cell lysates were also either immunoprecipitated with anti-occludin and
blotted with anti-claudin-1 (I) or directly probed with anti-claudin-1 antibody (J). Bar, 20 m.
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1997). We found that CGP77675, but not genistein or herbi-
mycin A (our unpublished data), was able to inhibit both
occludin tyrosine phosphorylation and tight junction reas-
sembly, indicating that only the inhibition of c-Yes by
CGP77675 was relevant. Moreover, we were unable to im-
munoprecipitate c-Src kinase with occludin antibodies (our
unpublished data).
Results from the literature also deny Src kinase a role in
cell junction assembly. Overexpression of v-Src in MDCK
epithelial cells rapidly disrupts cell-to-cell contacts and the
cells acquire a fibroblast-like morphology (Behrens et al.,
1993). In Caco-2 cells, expression of v-Src induces -catenin
and p120ctn tyrosine phosphorylation, redistribution of E-
cadherin to the cytosol, and disassembly of adherens junc-
tions (Gomez et al., 1999). These studies indicate that Src
kinase disrupts rather than promotes the assembly of cell-
cell junctions. Finally, two groups have reported that Triton-
insoluble membrane complexes isolated from MDCK cells
contain only one major tyrosine-phosphorylated protein,
p62c-yes (Sargiacomo et al., 1993; Arreaza et al., 1994). The
closely related tyrosine kinase p60c-src is undetectable in
these insoluble complexes even when this kinase is overex-
pressed in MDCK cells. Taken together, we believe that it is
c-Yes kinase that is involved in occludin tyrosine phosphor-
ylation and tight junction reassembly.
The effect of CGP77675 had a time window. By 8 h the
cells treated with CGP77675 had a TER value similar to that
of the control cells, indicating that the effect of CGP77675
was specific and not due to toxicity. The transient inhibitory
activity of CGP77675 may have been due to other nonrecep-
tor tyrosine kinases compensating for the loss of c-Yes ki-
nase function, as has been postulated (Stein et al., 1994;
Luton and Mostov, 1999).
c-Yes is a member of the Src family of tyrosine kinases and
was initially identified as a homolog of v-yes, the oncogene
of avian sarcoma virus Y73 (Ghysdael et al., 1981; Kitamura
et al., 1982; Sukegawa et al., 1987). The c-yes gene is widely
Figure 8. Effects of CGP77675, a c-Yes inhibitor, on tyrosine phos-
phorylation of occludin and tight junction formation. (A) Treatment
of MDCK II cells with CGP77675 led to occludin tyrosine dephos-
phorylation. Confluent cells were cultured in Ca2-free medium
overnight and then switched to Ca2-containing medium without
(C) or with the addition of 50 M genistein (Geni) or 200 nM
CGP77675 (CGP). After 2.5 h of treatment, cells were lysed in RIPA
buffer, immunoprecipitated with rabbit anti-occludin polyclonal an-
tibody, and blotted with anti-phosphotyrosine antibody. (B)
CGP77675 treatment disrupted tight junction formation. Same as in
A, cells were incubated in Ca2-free medium overnight and
switched to Ca2-containing medium for 2.5 h without (C), or with
the addition of 50 M genistein (Geni) or 200 nM CGP77675 (CGP).
Cells were fixed in methanol at 20°C and detected by indirect
immunofluorescence staining of anti-occludin antibody or anti-
ZO-1 antibody. Bar, 20 m.
Figure 9. Recovery of TER after Ca2 repletion was inhibited by
CGP77675 treatment. Cells were incubated in Ca2-free medium
overnight and then switched to the Ca2-containing medium for 0,
0.5, 1, 2, 3, and 4 h. At these time points TER measurements were
taken. Each TER measurement was normalized to the initial TER
value (before incubated in the Ca2-free medium) and was obtained
after background subtraction (contributed by filter and bath solu-
tion). The data represent the average  SE from five experiments.
Figure 10. Occludin/c-Yes complex was absent in minus calcium
condition and was disrupted by the CGP77675 treatment. (A) Cells
were incubated in Ca2-free medium for overnight and then
switched to the Ca2-containing medium for 2.5 h without (C), or
with the addition of 200 nM CGP77675 (CGP). Lane -Ca2 indicated
the cells without switching back to Ca2-containing medium. Cells
were lysed in RIPA buffer, immunoprecipitated by mouse anti-c-Yes
mAb, and blotted with rabbit anti-occludin antibody. (B) Same blot
as in A, but was stripped by 100 mM 2-mercaptoethanol, 2% SDS,
and 62.5 mM Tris-HCl pH 7.6 for 30 min at 55°C, and then reprobed
with anti-c-Yes antibody to show the equal amount of c-Yes immu-
noprecipitated in all three conditions.
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expressed in a variety of tissues, including epithelia such as
kidney, liver, lung, and intestine (reviewed in Brickell, 1992;
Thomas and Brugge, 1997). In the kidney, p62c-yes is found
in the epithelial cells of the proximal tubules, which are
engaged in transport and secretion (Sukegawa et al., 1990).
c-Yes is tightly associated with the membrane and active as
a nonreceptor protein tyrosine kinase (Sudol and Hanafusa,
1986; Sudol et al., 1988). Although there are studies of gene
structure and expression patterns, the function of c-Yes at
the cellular level has not been elucidated. Recently, it has
been reported that c-Yes kinase interacts with Yes-associated
protein 65 at the apical compartment of airway epithelia by
association with ezrin-radixin-moesin-binding phosphopro-
tein 50 kDa (also called Na/H exchanger regulatory fac-
tor; Mohler et al., 1999). These protein complexes may reg-
ulate apical signal transduction pathways leading to
changes in ion transport, cytoskeletal organization, or gene
expression in epithelial cells. Nusrat et al. (2000) demon-
strated that c-Yes kinase interacts with a 27 amino-acid
peptide of the human occludin sequence in vitro by using a
novel bait peptide method. Although c-Src and c-Yes share
high sequence homology outside of their unique domains,
Summy et al. (2000) showed recently that the SH3 and SH2
domains between c-Src and c-Yes are capable of directing
specificity in protein interactions. It is possible that c-Yes
interacts with occludin through these specific unique se-
quences.
Both the occludin-deficient mice and the mice with null
mutation of c-yes gene do not lead to an overt phenotype
related to the tight junction formation (Luton et al., 1999;
Saitou et al., 2000). It is well recognized now that the action
of a protein may appear redundant in a null mutant because
other related proteins compensate its function. For example,
the double mutant fyn/yes mice develop a renal disease
characterized as diffuse segmental glomerulosclerosis (Stein
et al., 1994). These mice show high levels of proteinuria and
hematuria. This phenotype was absent in fyn- or yes-defi-
cient mice. Our finding that c-Yes kinase is involved in
regulating tight junction formation and function by tyrosine
phosphorylation of tight junction protein may contribute to
the understanding of a subtype of renal pathology.
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